# US 2006/0154283 A1 · Computer-directed assembly of a polynucleotide encoding a target polypeptide

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0154283 A1
- Document ID: US20060154283A1
- Status: Published application
- Kind: A1
- Application number: 11/315,944
- Filed: 2005-12-22
- Published: 2006-07-13
- Earliest claimed: 2001-01-19
- Inventors: Glen Evans
- Web page: https://patentgrep.com/patent/US20060154283A1

## CPC

- C07K 1/00: General methods for the preparation of peptides {, i.e. processes for the organic chemical preparation of peptides or proteins of any length}
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12N 15/66: General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B 30/20: Sequence assembly
- B01J 2219/00659: Two-dimensional arrays
- B01J 2219/00689: using computers
- B01J 2219/00695: Synthesis control routines, e.g. using computer programs
- B01J 2219/007: Simulation or vitual synthesis
- B01J 2219/00722: Nucleotides
- C07B 2200/11: Compounds covalently bound to a solid support
- C40B 40/06: Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The present invention outlines a novel approach to utilizing the results of genomic sequence information by computer-directed polynucleotide assembly based upon information available in databases such as the human genome database. Specifically, the present invention may be used to select, synthesize and assemble a novel, synthetic target polynucleotide sequence encoding a target polypeptide. The target polynucleotide may encode a target polypeptide that exhibits enhanced or altered biological activity as compared to a model polypeptide encoded by a natural (wild-type) or model polynucleotide sequence.

## Claims

### Claim 1

A method of synthesizing a target polynucleotide comprising:
a) providing a target polynucleotide sequence;
b) identifying at least one initiating polynucleotide present in the target polynucleotide of a), wherein the initiating polynucleotide comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide resulting in a partially double-stranded polynucleotide comprised of a 5′ overhang and a 3′ overhang;
c) identifying a second polynucleotide present in the target polynucleotide of a), wherein the second polynucleotide is contiguous with the initiating polynucleotide and comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide resulting in a partially double-stranded polynucleotide comprised of a 5′ overhang, a 3′ overhang, or a 5′ overhang and a 3′ overhang, wherein at least one overhang of the second polynucleotide is complementary to at least one overhang of the initiating polynucleotide;
d) identifying a third polynucleotide present in the target polynucleotide of a), wherein the third polynucleotide is contiguous with the initiating sequence and comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide resulting in a partially double-stranded polynucleotide comprised of a 5′ overhang, a 3′ overhang, or a 5′ overhang and a 3′ overhang, wherein at least one overhang of the third polynucleotide is complementary to at least one overhang of the initiating polynucleotide which is not complementary to an overhang of the second polynucleotide;
e) contacting the initiating polynucleotide of b) with the second polynucleotide of c) and the third polynucleotide of d) under conditions and for such time suitable for annealing, the contacting resulting in a contiguous double-stranded polynucleotide, wherein the initiating sequence is extended bi-directionally;
f) in the absence of primer extension, optionally contacting the mixture of e) with a ligase under conditions suitable for ligation; and
g) optionally repeating b) through f) to sequentially add double-stranded polynucleotides to the extended initiating polynucleotide through repeated cycles of annealing and ligation, whereby a target polynucleotide is synthesized.

### Claim 2 (depends on 1)

The method of claim 1, wherein the target polynucleotide sequence encodes a target polypeptide.

### Claim 3 (depends on 2)

The method of claim 2, wherein the target polypeptide is a protein.

### Claim 4 (depends on 3)

The method of claim 3, wherein the protein is an enzyme.

### Claim 5 (depends on 1)

The method of claim 1, wherein the initiating polynucleotide sequence is identified by a computer program.

### Claim 6 (depends on 5)

The method of claim 5, wherein the computer program comprises the following algorithm:

### Claim 7 (depends on 1)

The method of claim 1, wherein the plus strand of the initiating, second or third polynucleotide is about 15 to 1000 nucleotides in length.

### Claim 8 (depends on 1)

The method of claim 1, wherein the plus strand of the initiating, second or third polynucleotide is about 20 to 500 nucleotides in length.

### Claim 9 (depends on 1)

The method of claim 1, wherein the plus strand of the initiating, second or third polynucleotide is about 25 to 100 nucleotides in length.

### Claim 10 (depends on 1)

The method of claim 1, wherein the minus strand of the initiating, second or third polynucleotide is about 15 to 1000 nucleotides in length.

### Claim 11 (depends on 1)

The method of claim 1, wherein the minus strand of the initiating, second or third polynucleotide is about 20 to 500 nucleotides in length.

### Claim 12 (depends on 1)

The method of claim 1, wherein the minus strand of the initiating, second or third polynucleotide is about 25 to 100 nucleotides in length.

### Claim 13 (depends on 1)

The method of claim 1, wherein the initiating polynucleotide is attached to a solid support.

### Claim 14

A method of synthesizing a target polynucleotide comprising:
a) providing a target polynucleotide sequence derived from a model sequence;
b) identifying at least one initiating polynucleotide sequence present in the target polynucleotide sequence of a), wherein the initiating polynucleotide comprises: 1) a first plus strand oligonucleotide; 2) a second plus strand oligonucleotide contiguous with the first plus strand oligonucleotide; and 3) a minus strand oligonucleotide comprising a first contiguous sequence that is at least partially complementary to the first plus strand oligonucleotide and second contiguous sequence which is at least partially complementary to the second plus strand oligonucleotide;
c) annealing the first plus strand oligonucleotide and the second plus strand oligonucleotide to the minus strand oligonucleotide of b) resulting in a partially double-stranded initiating polynucleotide comprised of a 5′ overhang and a 3′ overhang;
d) identifying a second polynucleotide sequence present in the target polynucleotide sequence of a), wherein the second polynucleotide sequence is contiguous with the initiating polynucleotide sequence and comprises: 1) a first plus strand oligonucleotide; 2) a second plus strand oligonucleotide contiguous with the first plus strand oligonucleotide; and 3) a minus strand oligonucleotide comprising a first contiguous sequence which is at least partially complementary to the first plus strand oligonucleotide and second contiguous sequence which is at least partially complementary to the second plus strand oligonucleotide;
e) annealing the first plus strand oligonucleotide and the second plus strand oligonucleotide to the minus strand oligonucleotide of d) resulting in a partially double-stranded second polynucleotide, wherein at least one overhang of the second polynucleotide is complementary to at least one overhang of the initiating polynucleotide;
f) identifying a third polynucleotide present in the target polynucleotide of a), wherein the third polynucleotide is contiguous with the initiating sequence and comprises: 1) a first plus strand oligonucleotide; 2) a second plus strand oligonucleotide contiguous with the first plus strand oligonucleotide; and 3) a minus strand oligonucleotide comprising a first contiguous sequence which is at least partially complementary to the first plus strand oligonucleotide and second contiguous sequence which is at least partially complementary to the second plus strand oligonucleotide;
g) annealing the first plus strand oligonucleotide and the second plus strand oligonucleotide to the minus strand oligonucleotide of f) resulting in a partially double-stranded second polynucleotide, wherein at least one overhang of the third polynucleotide is complementary to at least one overhang of the initiating polynucleotide and not complementary to an overhang of the second polynucleotide;
h) contacting the initiating polynucleotide of c) with the second polynucleotide of e) and the third polynucleotide of g) under conditions and for such time suitable for annealing, the contacting resulting in a contiguous double-stranded polynucleotide, wherein the initiating sequence is extended bi-directionally;
i) in the absence of primer extension, optionally contacting the mixture of h) with a ligase under conditions suitable for ligation; and
j) optionally repeating b) through i) to sequentially add double-stranded polynucleotides to the extended initiating polynucleotide through repeated cycles of annealing and ligation, whereby a target polynucleotide is synthesized.

### Claim 15

A method for synthesizing a target polynucleotide, comprising:
a) providing a target polynucleotide sequence;
b) identifying at least one initiating polynucleotide present in the target polynucleotide of a), wherein the initiating polynucleotide comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide;
c) contacting the initiating polynucleotide under conditions suitable for primer annealing with a first oligonucleotide having partial complementarity to the 3′ portion of the plus strand of the initiating polynucleotide, and a second oligonucleotide having partial complementarity to the 3′ portion of the minus strand of the initiating polynucleotide;
d) catalyzing under conditions suitable for primer extension: 1) polynucleotide synthesis from the 3′-hydroxyl of the plus strand of the initiating polynucleotide; 2) polynucleotide synthesis from the 3′-hydroxyl of the annealed first oligonucleotide; 3) polynucleotide synthesis from the 3′-hydroxyl of the minus strand of the initiating polynucleotide; and 4) polynucleotide synthesis from the 3′-hydroxyl of the annealed second oligonucleotide, wherein the initiating sequence is extended bi-directionally thereby forming a nascent extended initiating polynucleotide;
e) contacting the extended initiating polynucleotide of d) under conditions suitable for primer annealing with a third oligonucleotide having partial complementarity to the 3′ portion of the plus strand of the extended initiating polynucleotide, and a fourth oligonucleotide having partial complementarity to the 3′ portion of the minus strand of the extended initiating polynucleotide;
f) catalyzing under conditions suitable for primer extension: 1) polynucleotide synthesis from the 3′-hydroxyl of the plus strand of the extended initiating polynucleotide; 2) polynucleotide synthesis from the 3′-hydroxyl of the annealed third oligonucleotide; 3) polynucleotide synthesis from the 3′-hydroxyl of the minus strand of the extended initiating polynucleotide; and 4) polynucleotide synthesis from the 3′-hydroxyl of the annealed fourth oligonucleotide, wherein the extended initiating sequence is extended bi-directionally thereby forming a nascent extended initiating polynucleotide; and
g) optionally repeating. e) through f) as desired, resulting in formation of the target polynucleotide sequence.

### Claim 16 (depends on 15)

The method of claim 15, wherein the target polynucleotide sequence encodes a target polypeptide.

### Claim 17 (depends on 16)

The method of claim 16, wherein the target polypeptide is a protein.

### Claim 18 (depends on 17)

The method of claim 17, wherein the protein is an enzyme.

### Claim 19 (depends on 15)

The method of claim 15, wherein the initiating polynucleotide is identified by an algorithm.

### Claim 20

A method of synthesizing a target polynucleotide comprising:
a) providing a target polynucleotide sequence;
b) identifying at least one initiating polynucleotide present in the target polynucleotide of a), wherein the initiating polynucleotide comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide resulting in a partially double-stranded polynucleotide comprised of at least a 5′ overhang or a 3′ overhang;
c) identifying a second polynucleotide present in the target polynucleotide of a), wherein the second polynucleotide is contiguous with the initiating polynucleotide and comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide resulting in a partially double-stranded polynucleotide comprised of a 5′ overhang, a 3′ overhang, or a 5′ overhang and a 3′ overhang, wherein at least one overhang of the second polynucleotide is complementary to the overhang of the initiating polynucleotide;
d) contacting the initiating polynucleotide of b) with the second polynucleotide of c) under conditions and for such time suitable for annealing, the contacting resulting in a contiguous double-stranded polynucleotide, wherein the initiating sequence is extended uni-directionally;
e) in the absence of primer extension, optionally contacting the mixture of e) with a ligase under conditions suitable for ligation; and
f) optionally repeating b) through e) to sequentially add double-stranded polynucleotides to the extended initiating polynucleotide through repeated cycles of annealing and ligation, whereby a target polynucleotide is synthesized.

### Claim 21 (depends on 15)

The method of claim 15, wherein the plus strand of the initiating, second or third polynucleotide is about 15 to 1000 nucleotides in length.

### Claim 22 (depends on 15)

The method of claim 15, wherein the plus strand of the initiating, second or third polynucleotide is about 20 to 500 nucleotides in length.

### Claim 23 (depends on 15)

The method of claim 15, wherein the plus strand of the initiating, second or third polynucleotide is about 25 to 100 nucleotides in length.

### Claim 24 (depends on 15)

The method of claim 15, wherein the minus strand of the initiating, second or third polynucleotide is about 15 to 1000 nucleotides in length.

### Claim 25 (depends on 15)

The method of claim 15, wherein the minus strand of the initiating, second or third polynucleotide is about 20 to 500 nucleotides in length.

### Claim 26 (depends on 15)

The method of claim 15, wherein the minus strand of the initiating, second or third polynucleotide is about 25 to 100 nucleotides in length.

### Claim 27 (depends on 15)

The method of claim 15, wherein the initiating polynucleotide is attached to a solid support.

### Claim 28

A method for isolating a target polypeptide encoded by a target polynucleotide, comprising:
a) providing a target polynucleotide sequence derived from a model sequence;
b) identifying at least one initiating polynucleotide present in the target polynucleotide of a), wherein the initiating polynucleotide comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide resulting in a partially double-stranded polynucleotide comprised of a 5′ overhang and a 3′ overhang;
c) identifying a second polynucleotide present in the target polynucleotide of a), wherein the second polynucleotide is contiguous with the initiating sequence and comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide resulting in a partially double-stranded polynucleotide comprised of a 5′ overhang, a 3′ overhang, or a 5′ overhang and a 3′ overhang, wherein at least one overhang of the second polynucleotide is complementary to at least one overhang of the initiating sequence;
d) identifying a third polynucleotide present in the target polynucleotide of a), wherein the third polynucleotide is contiguous with the initiating sequence and comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide resulting in a partially double-stranded polynucleotide comprised of a 5′ overhang, a 3′ overhang, or a 5′ overhang and a 3′ overhang, wherein at least one overhang of the third polynucleotide is complementary to at least one overhang of the initiating sequence which is not complementary to an overhang of the second polynucleotide;
e) contacting the initiating polynucleotide of b) with the second polynucleotide of c) and the third polynucleotide of d) under conditions and for such time suitable for annealing, the contacting resulting in a contiguous double-stranded polynucleotide, wherein the initiating sequence is extended bi-directionally;
f) in the absence of primer extension, optionally contacting the mixture of e) with a ligase under conditions suitable for ligation;
g) optionally repeating b) through f) to sequentially add double-stranded polynucleotides to the extended initiating sequence through repeated cycles of annealing and ligation, whereby a target polynucleotide is synthesized;
h) incorporating the target polynucleotide of g) in an expression vector;
i) introducing the expression vector of h) into a suitable host cell;
j) culturing the cell of i) under conditions and for such time as to promote the expression of the target polypeptide encoded by the target polynucleotide; and
k) isolating the target polypeptide.

### Claim 29 (depends on 28)

The method of claim 28, wherein the target polypeptide is a chimeric protein.

### Claim 30 (depends on 28)

The method of claim 28, wherein the target polypeptide is a fusion protein.

### Claim 31 (depends on 28)

The method of claim 28, wherein the expression vector is a bacterial expression vector.

### Claim 32 (depends on 29)

The method of claim 29, wherein the expression vector is an animal cell expression vector.

### Claim 33 (depends on 28)

The method of claim 28, wherein the expression vector is an insect cell expression vector.

### Claim 34 (depends on 28)

The method of claim 28, wherein the expression vector is a retroviral vector.

### Claim 35 (depends on 29)

The method of claim 29, wherein the expression vector is contained in a host cell.

### Claim 36 (depends on 35)

The method of claim 35, wherein the host cell is a prokaryotic cell.

### Claim 37 (depends on 35)

The method of claim 35, wherein the host cell is a eukaryotic cell.

### Claim 38 (depends on 1, 14, 15, 27)

The method of claims 1, 14, 15 or 27, wherein the oligonucleotides are produced by synthesis on a automated DNA synthesizer.

### Claim 39

A method of synthesizing a target polynucleotide comprising:
a) providing a target polynucleotide sequence derived from a model sequence;
b) chemically synthesizing a plurality of single-stranded oligonucleotides each of which is partially complementary to at least one oligonucleotide present in the plurality, wherein the sequence of the plurality of oligonucleotides is a contiguous sequence of the target polynucleotide;
c) contacting the partially complementary oligonucleotides of b) under conditions and for such time suitable for annealing, the contacting resulting in a plurality of partially double-stranded polynucleotides, wherein each double-stranded polynucleotide is comprised of a 5′ overhang and a 3′ overhang;
d) identifying at least one initiating polynucleotide derived from the model sequence, wherein the initiating polynucleotide is present in the plurality of double-stranded polynucleotides set forth in c);
e) in the absence of primer extension, subjecting a mixture comprising the initiating polynucleotide and 1) a double-stranded polynucleotide that will anneal to the 5′ portion of said initiating and sequence; 2) a double-stranded polynucleotide that will anneal to the 3′ portion of the initiating polynucleotide; and 3) a DNA ligase under conditions suitable for annealing and ligation, wherein the initiating polynucleotide is extended bi-directionally;
f) sequentially annealing double-stranded polynucleotides to the extended initiating polynucleotide through repeated cycles of annealing, whereby the target polynucleotide is produced.

### Claim 40 (depends on 39)

The method of claim 39, wherein the oligonucleotides are produced by synthesis on an automated DNA synthesizer.

### Claim 41

A computer program, stored on a computer-readable medium, for generating a target polynucleotide sequence, the computer program comprising instructions for causing a computer system to:
a) identify an initiating polynucleotide sequence contained in the target polynucleotide sequence;
b) parse the target polynucleotide sequence into multiply distinct, partially complementary, oligonucleotides;
c) control assembly of the target polynucleotide sequence by controlling the bi-directional extension of the initiating polynucleotide sequence by the sequential addition of partially complementary oligonucleotides resulting in a contiguous double-stranded polynucleotide.

### Claim 42 (depends on 41)

The computer program of claim 41, wherein the parsing is performed by an algorithm.

### Claim 43 (depends on 42)

The computer program of claim 42, wherein the algorithm comprises:
$Overlap = <STDIN>;
$seqlen = length($sequence);
}
$revcomp = “”;
for ($i = $seqlen−1; $i >= 0; $i−−)
{ $base = substr($sequence,$i,1);
if ($base eq “a”){$comp = “T”;}
elsif ($base eq “t”){$comp = “A”;}
elsif ($base eq “g”){$comp = “C”;}
elsif ($base eq “c”){$comp = “G”;}
elsif ($base eq “A”){$comp = “T”;}
elsif ($base eq “T”){$comp = “A”;}
elsif ($base eq “G”){$comp = “C”;}
elsif ($base eq “C”){$comp = “G”;}
else {$comp = “X”};
$revcomp = $revcomp.$comp;
}
print OUT “Forward oligos\n”;
print “Forward oligos\n”;
$r = 1;
for ($i = 0; $i <= $seqlen −1; $i+=$OL)
{ $oligo = substr($sequence,$i,$OL);
print OUT “soligname F- $r $oligo\n”;
print “$oligname F- $r $oligo\n”;
$r = $r + 1;
}
$r = 1;
for ($i = $seqlen − $Overlap − $OL; $i >= 0; $i−=$OL)
{
print OUT “\n”;
print “\n”;
$oligo = substr($revcomp,$i,$OL);
print OUT “$oligname R- $r $oligo”;
print “$oligname R- $r $oligo”;
$r = $r + 1;
}
$oligo = substr($revcomp,1, $Overlap);
print OUT “$oligo\n”;
print “$oligo\n”;
wherein
$oligoname is the identifier name for the list and for
each component #oligonucleotide;
$OL is the length of each component oligonucleotide;
$Overlap is the length of the overlap in bases between
each forward and each #reverse oligonucleotide;
$sequence is the DNA sequence in bases;
$seqlen is the length of the DNA sequence in bases;
$bas is the individual base in a sequence;
$forseq is the sequence of a forward oligonucleotide;
$revseq is the sequence of a reverse oligonucleotide;
$revcomp is the reverse complemented sequence of the
gene;
$oligonameF-[ ] is the list of parsed forward oligos;
and
$oligonameR-[ ] is the list of parsed reverse oligos.

### Claim 44 (depends on 43)

The computer program of claim 43, wherein the forward sequence is optionally converted to upper case using an algorithm comprising:
$forseq = “”;
for ($j = 0; $j <= seqlen−1; $j ++)
{ $bas = substr($sequence,$j,1);
if ($bas eq “a”){$cfor = “A”;}
elsif ($bas eq “t”){$cfor = “T”;}
elsif ($bas eq “c”){$cfor = “C”;}
elsif ($bas eq “g”){$cfor = “G”;}
elsif ($bas eq “A”){$cfor = “A”;}
elsif ($bas eq “T”){$cfor = “T”;}
elsif ($bas eq “C”){$cfor = “C”;}
elsif ($bas eq “G”){$cfor = “G”;}
else {$cfor = “X”};
$forseq = $forseq.$cfor;
print OUT “$j \n”;
wherein
$seqlen is the length of the DNA sequence in bases
$bas is the individual base in a sequence
$forseq is the sequence of a forward
oligonucleotide.

### Claim 45

A computer-assisted method for synthesizing a target polynucleotide encoding a target polypeptide derived from a model sequence using a programmed computer including a processor, an input device, and an output device, comprising:
a) inputting into the programmed computer, through the input device, data including at least a portion of the target polynucleotide sequence encoding a target polypeptide;
b) determining, using the processor, the sequence of at least one initiating polynucleotide present in the target polynucleotide sequence
c) selecting, using the processor, a model for synthesizing the target polynucleotide sequence based on the position of the initiating sequence in the target polynucleotide sequence using overall sequence parameters necessary for expression of the target polypeptide in a biological system; and
d) outputting, to the output device, the results of the at least one determination.

### Claim 46 (depends on 45)

The method of claim 45, further comprising predicting, using the processor, whether changing the model sequence to the target polynucleotide will have an effect on the target polypeptide encoded by the target polynucleotide based on at least one physical, structural or phylogenetic characteristic of the model sequence.

### Claim 47

A method for automated synthesis of a target polynucleotide sequence, comprising:
a) providing a user with an opportunity to communicate a desired target polynucleotide sequence;
b) allowing the user to transmit the desired target polynucleotide sequence to a server;
c) providing the user with a unique designation;
d) obtaining the transmitted target polynucleotide sequence provided by the user.

### Claim 48 (depends on 47)

The method of claim 47, further comprising:
f) identifying at least one initiating polynucleotide present in the target polynucleotide of e), wherein the initiating polynucleotide comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide resulting in a partially double-stranded polynucleotide comprised of a 5′ overhang and a 3′ overhang;
g) identifying a second polynucleotide present in the target polynucleotide of e), wherein the second polynucleotide is contiguous with the initiating polynucleotide and comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide resulting in a partially double-stranded polynucleotide comprised of a 5′ overhang, a 3′ overhang, or a 5′ overhang and a 3′ overhang, wherein at least one overhang of the second polynucleotide is complementary to at least one overhang of the initiating polynucleotide;
h) identifying a third polynucleotide present in the target polynucleotide of e), wherein the third polynucleotide is contiguous with the initiating sequence and comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide resulting in a partially double-stranded polynucleotide comprised of a 5′ overhang, a 3′ overhang, or a 5′ overhang and a 3′ overhang, wherein at least one overhang of the third polynucleotide is complementary to at least one overhang of the initiating polynucleotide which is not complementary to an overhang of the second polynucleotide;
i) contacting the initiating polynucleotide of f) with the second polynucleotide of g) and the third polynucleotide of h) under conditions and for such time suitable for annealing, the contacting resulting in a contiguous double-stranded polynucleotide, wherein the initiating sequence is extended bi-directionally;
j) in the absence of primer extension, optionally contacting the mixture of i) with a ligase under conditions suitable for ligation; and
k) optionally repeating f) through k) to sequentially add double-stranded polynucleotides to the extended initiating polynucleotide through repeated cycles of annealing and ligation, whereby a target polynucleotide is synthesized.

### Claim 49 (depends on 47)

The method of claim 47, further comprising:
f) identifying at least one initiating polynucleotide present in the target polynucleotide of e), wherein the initiating polynucleotide comprises at least one plus strand oligonucleotide annealed to at least one minus strand oligonucleotide;
g) contacting the initiating polynucleotide under conditions suitable for primer annealing with a first oligonucleotide having partial complementarity to the 3′ portion of the plus strand of the initiating polynucleotide, and a second oligonucleotide having partial complementarity to the 3′ portion of the minus strand of the initiating polynucleotide;
h) catalyzing under conditions suitable for primer extension: 1) polynucleotide synthesis from the 3′-hydroxyl of the plus strand of the initiating polynucleotide; 2) polynucleotide synthesis from the 3′-hydroxyl of the annealed first oligonucleotide; 3) polynucleotide synthesis from the 3′-hydroxyl of the minus strand of the initiating polynucleotide; and 4) polynucleotide synthesis from the 3′-hydroxyl of the annealed second oligonucleotide, wherein the initiating sequence is extended bi-directionally thereby forming a nascent extended initiating polynucleotide;
i) contacting the extended initiating polynucleotide of h) under conditions suitable for primer annealing with a third oligonucleotide having partial complementarity to the 3′ portion of the plus strand of the extended initiating polynucleotide, and a fourth oligonucleotide having partial complementarity to the 3′ portion of the minus strand of the extended initiating polynucleotide;
j) catalyzing under conditions suitable for primer extension: 1) polynucleotide synthesis from the 3′-hydroxyl of the plus strand of the extended initiating polynucleotide; 2) polynucleotide synthesis from the 3′-hydroxyl of the annealed third oligonucleotide; 3) polynucleotide synthesis from the 3′-hydroxyl of the minus strand of the extended initiating polynucleotide; and 4) polynucleotide synthesis from the 3′-hydroxyl of the annealed fourth oligonucleotide, wherein the extended initiating sequence is extended bi-directionally thereby forming a nascent extended initiating polynucleotide; and
k) optionally repeating f) through j) as desired, resulting in formation of the target polynucleotide sequence.

### Claim 50

A method for automated synthesis of a polynucleotide, comprising:
a) providing a user with a mechanism for communicating a model polynucleotide sequence;
b) optionally providing the user with an opportunity to communicate at least one desired modification to the model sequence if desired;
c) allowing the user to transmit the model sequence and desired modification to a server;
d) providing user with a unique designation;
e) obtaining the transmitted model sequence and desired modification provided by the user;
f) inputting into a programmed computer, through an input device, data including at least a portion of the model polynucleotide sequence;
g) determining, using the processor, the sequence of the model polynucleotide sequence containing the desired modification;
h) further determining, using the processor, at least one initiating polynucleotide sequence present in the model polynucleotide sequence
i) selecting, using the processor, a model for synthesizing the modified model polynucleotide sequence based on the position of the initiating sequence in the model polynucleotide sequence; and
j) outputting, to-the output device, the results of the at least one determination.

### Claim 51

An isolated polynucleotide composition comprising:
a) an initiating polynucleotide comprising a plus strand and a minus strand, wherein the plus or minus strand is modified to incorporate a moiety that binds to a solid support;
b) a first primer suitable for primer extension having partial complementarity to the 3′ portion of the plus strand of the initiating polynucleotide
c) a second primer suitable for primer extension having partial complementarity to the 3′ portion of the minus strand of the initiating polynucleotide; and
d) a solid support matrix, wherein each of the first and second primers consists of about 25 to 1000 nucleotides.

### Claim 52

An isolated polynucleotide composition comprising:
a) an initiating polynucleotide comprising a plus strand and a minus strand, wherein the plus or minus strand is modified to incorporate a moiety that binds to a solid support;
b) a first primer suitable for primer extension having partial complementarity to the 3′ portion of the plus strand of the initiating polynucleotide
c) a second primer suitable for primer extension having partial complementarity to the 3′ portion of the minus strand of the initiating polynucleotide; and
d) a solid support matrix,
wherein each of the first and second primers consists of about 25 to 1000 nucleotides.
